Cargando…

Resolution of persistent corneal erosion after administration of topical rebamipide

Rebamipide is an antiulcer agent used to treat gastric ulcer and gastritis. Biological effects of rebamipide include cytoprotection, wound healing, and anti-inflammatory properties that are known to be universal for a variety of tissues in addition to gastrointestinal mucosa. The therapeutic effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashima, Tomoyuki, Akiyama, Hideo, Miura, Fumihide, Kishi, Shoji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437954/
https://www.ncbi.nlm.nih.gov/pubmed/22969286
http://dx.doi.org/10.2147/OPTH.S35122
_version_ 1782242841602293760
author Kashima, Tomoyuki
Akiyama, Hideo
Miura, Fumihide
Kishi, Shoji
author_facet Kashima, Tomoyuki
Akiyama, Hideo
Miura, Fumihide
Kishi, Shoji
author_sort Kashima, Tomoyuki
collection PubMed
description Rebamipide is an antiulcer agent used to treat gastric ulcer and gastritis. Biological effects of rebamipide include cytoprotection, wound healing, and anti-inflammatory properties that are known to be universal for a variety of tissues in addition to gastrointestinal mucosa. The therapeutic effects of rebamipide eye drops are due to its ability to increase corneal and conjunctival mucin-like substances and improve corneal and conjunctival injury in vivo. In this paper, we report a case of Sjögren’s syndrome with complete disappearance of corneal erosion after administration of rebamipide eye drops. This was observed even though corneal erosion had not improved for 6 months after punctal occlusion surgery. The patient was a 33-year-old female, diagnosed with Sjögren’s syndrome by a salivary gland biopsy. The corneal and conjunctival surfaces were filled with dense erosions, which did not improve with topical drugs. Punctal plugs were applied several times; however, the plugs were repeatedly shed. All four puncta of both eyelids were surgically occluded, and both corneal and conjunctival erosion was clearly improved. However, the erosion in the inferior cornea of both eyes had not improved for 6 months after surgery. We used the newly approved topical rebamipide for treatment of this patient. The corneal erosion gradually improved and completely disappeared 4 weeks after administration of the drug. Dry eye sensation disappeared at the same time. Both membrane-associated mucin and secreted mucin in the ocular surface are thought to be essential for maintenance of the tear film. Induction of mucin from ocular surface epithelium could be an effective treatment in cases of dry eye caused by mucin deficiency. Through its various mechanisms, rebamipide improves ocular surface conditions. To our knowledge, this is the first clinical case report using rebamipide ophthalmic solution. This drug may provide a novel approach to treat drying diseases of the eye.
format Online
Article
Text
id pubmed-3437954
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-34379542012-09-11 Resolution of persistent corneal erosion after administration of topical rebamipide Kashima, Tomoyuki Akiyama, Hideo Miura, Fumihide Kishi, Shoji Clin Ophthalmol Original Research Rebamipide is an antiulcer agent used to treat gastric ulcer and gastritis. Biological effects of rebamipide include cytoprotection, wound healing, and anti-inflammatory properties that are known to be universal for a variety of tissues in addition to gastrointestinal mucosa. The therapeutic effects of rebamipide eye drops are due to its ability to increase corneal and conjunctival mucin-like substances and improve corneal and conjunctival injury in vivo. In this paper, we report a case of Sjögren’s syndrome with complete disappearance of corneal erosion after administration of rebamipide eye drops. This was observed even though corneal erosion had not improved for 6 months after punctal occlusion surgery. The patient was a 33-year-old female, diagnosed with Sjögren’s syndrome by a salivary gland biopsy. The corneal and conjunctival surfaces were filled with dense erosions, which did not improve with topical drugs. Punctal plugs were applied several times; however, the plugs were repeatedly shed. All four puncta of both eyelids were surgically occluded, and both corneal and conjunctival erosion was clearly improved. However, the erosion in the inferior cornea of both eyes had not improved for 6 months after surgery. We used the newly approved topical rebamipide for treatment of this patient. The corneal erosion gradually improved and completely disappeared 4 weeks after administration of the drug. Dry eye sensation disappeared at the same time. Both membrane-associated mucin and secreted mucin in the ocular surface are thought to be essential for maintenance of the tear film. Induction of mucin from ocular surface epithelium could be an effective treatment in cases of dry eye caused by mucin deficiency. Through its various mechanisms, rebamipide improves ocular surface conditions. To our knowledge, this is the first clinical case report using rebamipide ophthalmic solution. This drug may provide a novel approach to treat drying diseases of the eye. Dove Medical Press 2012 2012-08-29 /pmc/articles/PMC3437954/ /pubmed/22969286 http://dx.doi.org/10.2147/OPTH.S35122 Text en © 2012 Kashima et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Kashima, Tomoyuki
Akiyama, Hideo
Miura, Fumihide
Kishi, Shoji
Resolution of persistent corneal erosion after administration of topical rebamipide
title Resolution of persistent corneal erosion after administration of topical rebamipide
title_full Resolution of persistent corneal erosion after administration of topical rebamipide
title_fullStr Resolution of persistent corneal erosion after administration of topical rebamipide
title_full_unstemmed Resolution of persistent corneal erosion after administration of topical rebamipide
title_short Resolution of persistent corneal erosion after administration of topical rebamipide
title_sort resolution of persistent corneal erosion after administration of topical rebamipide
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437954/
https://www.ncbi.nlm.nih.gov/pubmed/22969286
http://dx.doi.org/10.2147/OPTH.S35122
work_keys_str_mv AT kashimatomoyuki resolutionofpersistentcornealerosionafteradministrationoftopicalrebamipide
AT akiyamahideo resolutionofpersistentcornealerosionafteradministrationoftopicalrebamipide
AT miurafumihide resolutionofpersistentcornealerosionafteradministrationoftopicalrebamipide
AT kishishoji resolutionofpersistentcornealerosionafteradministrationoftopicalrebamipide